Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to investigate the predictive value of the presence or absence of cardiac activity by bedside ultrasound during cardiac arrest. The investigators anticipate based on previous research that patients who suffer a cardiac arrest and have cardiac activity on bedside ultrasound will have a greater chance of surviving to hospital admission. The investigators hypothesis is that the mortality rate in patients in cardiac arrest with no cardiac activity by ultrasound will have a mortality rate of 100%.


Clinical Trial Description

This is a multi-center, prospective, observational trial involving sites across the United States and Canada. Patients will be enrolled through the emergency department either presenting in cardiac arrest, or going into cardiac arrest while in the emergency department. Patients who develop cardiac arrest as inpatients will also be enrolled at centers capable of enrolling inpatients subjects. Advanced Cardiac Life Support (ACLS) protocols and institutional policies for resuscitation will be followed, as is the current standard of care. A patient encounter will conclude upon halting of cardiopulmonary resuscitation. Final disposition of the patient will be evaluated by chart review.

After the initial cardiac arrest and disposition there will be no further direct patient interactions as part of the study except in the setting of repeat cardiac arrest. Patients that have a repeat arrest can undergo a repeated ultrasound exam if they continue to meet inclusion criteria. The repeat episode will be recorded as a continuation of the event and not as a separate enrollment.

Subject data, with Protected Health Information (PHI) removed, will be uploaded into the REDcap web-based database as soon as possible and within 7 days of final disposition. Data will be obtained from initial patient encounter, patient records, and EMS records when available. Additional data may be obtained by chart review to obtain data points not available at initial contact. Individual sites will keep secured records to enable identification of the patient source if data review is required.

Patient information will include 6 types of data, past medical history, events surrounding the cardiac arrest, actions taken by health care professionals, peri-arrest presentation, peri-arrest interventions, and patient outcomes. Health care professional actions can include ACLS medication administration, airway management, chest compressions, defibrillation, pacing, and other resuscitative interventions. Specific data points are listed in the paper version of electronic Case Report Form, CRF, see Appendix A.

Sonography will not hinder or impair resuscitative efforts in any way, including halting CPR or prolonging pauses in cardiopulmonary rescusitation (CPR). Sonographic images will be obtained during designated pauses in chest compressions, as is routine care, during CPR for pulse checks, rhythm checks, and necessary resuscitative procedures.

Single or multi-view echocardiography will be performed as appropriate to obtain diagnostic information for each particular patient during resuscitative efforts. Recording of the image loops will be performed during image acquisition according to standard technology availability at each site. To facilitate image acquisition, the ultrasound probe may be placed in the epigastrium or parasternal region during CPR with the heart centered in the field of view, if it will not interfere with ongoing resuscitation. Recording of the images can begin immediately upon pauses of CPR using whatever means are available at the site. Sonographic images will be obtained by competent personnel with experience in bedside cardiac ultrasound. This information will be made available to the physician taking care of the patient

Ultrasound images will consist of a single or multiple view(s) that can include subxiphoid, parasternal long axis, and/or apical 4 chamber. While not primarily preferred views; also acceptable are parasternal short axis or apical 2 chamber views. Image requirements will be based on adequate echocardiographic windows and adequate image acquisition as determined by the physician performing the bedside ultrasound. In the setting of difficult to image patients a combination of views may be required to obtain adequate information.

There will be at least two ultrasound exams performed. The initial ultrasound exam and video will be obtained upon the first pause for pulse or rhythm check once the inclusion criteria are met and no exclusion criteria are present. The final ultrasound exam and video will be obtained when resuscitative efforts are halted.

All ultrasound images will be recorded for later review by the Regional Coordinating Site for each Local Site. Ultrasound videos will be interpreted during acquisition as cardiac activity present or absent and valvular movement present or absent. Specific video file formats that are acceptable include MPEG4, Quicktime (MOV), DV, AVI, and WMV. Files will be forwarded at least monthly to the Site Coordinator for the Regional Site and sent within 1 week of request by the regional coordinating site.

INITIAL INTERPRETATION OF CARDIAC IMAGES The Local Site PI will interpret ultrasound images and the information will be uploaded into the central database or another database specified by the Central Coordinating Site. Cardiac activity will initially categorize as "Cardiac Activity Present", "Cardiac Activity Absent", Valve Movement Present", or Valve Movement Absent". Cardiac activity is defined as any intrinsic movement of the myocardium, but not isolated movement of the cardiac valves. Valve movement is defined as any movement of the cardiac valves.

FINAL INTERPRETATION OF CARDIAC IMAGES

Cardiac images will be reviewed by regional site PIs for sub-categories of cardiac activity. A heart with any intrinsic cardiac movement outside of isolated valvular motion will be categorized as "Cardiac Activity Present". Ultrasound images in patients with cardiac activity will be further categorized as:

1. Cardiac motion but No decrease in chamber size

2. Cardiac motion with a decrease in chamber size <10%

3. Cardiac motion with a decrease in chamber size of >10%.

The estimated duration that each subject will participate is the length of the cardiopulmonary resuscitation which can vary by patient, but can be from 15 minutes to 1 hour, with later follow up (hours to days later) to determine final disposition.

A summary of the sequence and duration of all research activities is as follows.

Patient interactions (estimated 15 minutes to 1 hour)

- Patient identified to be in cardiac arrest with confirmation of no pulse.

- Chest compressions and ACLS protocols initiated as per standard care

- Bedside ultrasound of heart performed and interpreted during standard pauses in cardiac compressions as per routine care at institution (3-6 seconds)

- ACLS protocols continue as per standard care by treating physician

- Resuscitation activities halted by either pronouncement of patient or return of spontaneous circulation allowing disposition planning

- Bedside ultrasound of heart performed and interpreted (3-6 seconds)

Data Acquisition (Immediate to days later via chart review)

- Final patient disposition determined

- Interval events recorded (ie: repeat cardiopulmonary arrest)

Data Management (immediate to days or weeks later)

- Subject data with PHI removed entered into research database

- Subject data with PHI removed updated in research database if CRF not completed initially

- Cardiac ultrasound images with PHI removed sent to regional site for review ;


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01446471
Study type Observational
Source University of Massachusetts, Worcester
Contact
Status Completed
Phase N/A
Start date January 2010
Completion date November 2015

See also
  Status Clinical Trial Phase
Recruiting NCT06048068 - Removing Surrogates' Uncertainty to Reduce Fear and Anxiety After Cardiac Events N/A
Recruiting NCT05558228 - Accuracy of Doppler Ultrasound Versus Manual Palpation of Pulse in Cardiac Arrest
Completed NCT03685383 - Cytokine Adsorption in Post-cardiac Arrest Syndrome in Patients Requiring Extracorporeal Cardiopulmonary Resuscitation N/A
Completed NCT04584645 - A Digital Flu Intervention for People With Cardiovascular Conditions N/A
Completed NCT04619498 - Effectiveness of an Interactive Cognitive Support Tablet App to Improve the Management of Pediatric Cardiac Arrest N/A
Not yet recruiting NCT05649891 - Checklists Resuscitation Emergency Department N/A
Withdrawn NCT02352350 - Lactate in Cardiac Arrest N/A
Completed NCT03024021 - Cerebral Oxymetry and Neurological Outcome in Therapeutic Hypothermia
Completed NCT02275234 - Care After Resuscitation
Completed NCT02247947 - Proteomics to Identify Prognostic Markers After CPR and to Estimate Neurological Outcome
Completed NCT01944605 - Intestinal Ischemia as a Stimulus for Systemic Inflammatory Response After Cardiac Arrest N/A
Completed NCT01936597 - Prospective Study of 3 Phone Assistance Strategies to Achieve a Continuous Cardiac Massage N/A
Completed NCT01972087 - Simulation Training to Improve 911 Dispatcher Identification of Cardiac Arrest N/A
Active, not recruiting NCT01239420 - Norwegian Cardio-Respiratory Arrest Study
Completed NCT00878644 - Therapeutic Hypothermia to Improve Survival After Cardiac Arrest in Pediatric Patients-THAPCA-OH [Out of Hospital] Trial Phase 3
Completed NCT01191736 - Ultra-Brief Versus Brief Hands Only CPR Video Training With and Without Psychomotor Skill Practice N/A
Completed NCT00880087 - Therapeutic Hypothermia to Improve Survival After Cardiac Arrest in Pediatric Patients-THAPCA-IH [In Hospital] Trial N/A
Completed NCT00729794 - Vasopressin, Epinephrine, and Steroids for Cardiac Arrest Phase 3
Recruiting NCT00441753 - Cerebral Bloodflow and Carbondioxide Reactivity During Mild Therapeutic Hypothermia in Patients After Cardiac Arrest N/A
Completed NCT00347477 - Fluid Shifts in Patients Treated With Therapeutic Hypothermia After Cardiac Arrest Phase 3